No Data
An Overview of Adaptimmune Therapeutics's Earnings
Earnings Preview: ADAP to Report Financial Results Post-market on November 13
Express News | Adaptimmune Therapeutics PLC - Receives Nasdaq Notice for Non-Compliance With Minimum Bid Price
Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024
Express News | Adaptimmune Therapeutics: Entered Mutual Release and Resolution Agreement With Genentech Inc & F. Hoffmann-La Roche Ltd
Adaptimmune to Participate in Two Bank Conferences This September
hardeep dhaliwal : How’s that stock for long term according to you?